Ante Sven Lundberg

USPTO Granted Patents = 17 (Patent Applications = 31)

EPO Patents = 12 (Patent Applications = 31)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

9 out of 77

Crispr Therapeutics Ag

patents

8 out of 1,149

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2021-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12442020 - Materials and methods for treatment of pain related disorders (2025-10-14),

2. 12186406 - Materials and methods for treatment of hereditary haemochromatosis (2025-01-07),

3. 12161674 - CRISPR-CAS9 modified CD34+ human hematopoietic stem and progenitor cells and uses thereof (2024-12-10),

4. 12053531 - Materials and methods for treatment of Duchenne Muscular Dystrophy (2024-08-06),

5. 12043843 - Materials and methods for treatment of hemoglobinopathies (2024-07-23),

6. 11920148 - Compositions and methods for gene editing (2024-03-05),

7. 11866727 - Materials and methods for treatment of glycogen storage disease type 1A (2024-01-09),

8. 11851653 - Materials and methods for treatment of alpha-1 antitrypsin deficiency (2023-12-26),

9. 11801313 - Materials and methods for treatment of pain related disorders (2023-10-31),

10. 11564997 - Materials and methods for treatment of friedreich ataxia and other related disorders (2023-01-31),

11. 11559588 - Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders (2023-01-24),

12. 11459587 - Materials and methods for treatment of pain related disorders (2022-10-04),

13. 11427838 - Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders (2022-08-30),

14. 11407997 - Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders (2022-08-09),

15. 11369692 - Materials and methods for treatment of Duchenne Muscular Dystrophy (2022-06-28),

Title: Ante Sven Lundberg - Innovative Inventor from Cambridge

Introduction: Ante Sven Lundberg is a renowned inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Ante Sven Lundberg holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Lundberg has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation. His work has been instrumental in shaping the future of technology.

Collaborations: Lundberg has collaborated with top universities and multinational corporations on cutting-edge projects, fostering a culture of innovation and knowledge-sharing. His collaborative efforts have led to the development of revolutionary products and solutions.

Conclusion: Ante Sven Lundberg's passion for innovation and his relentless pursuit of excellence have established him as a visionary inventor in the tech industry, with a legacy that continues to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.